ARIAD Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals

ARIA 23.99

0.0%

Feb 17 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: r. peter Dale who wrote (123)	6/20/1997 2:05:00 PM
From: scaram(o)uche	of 4474

Yeah, I know..... if I used your statement, it wouldn't be criticism of ARIA, it would be used as an example of how to approach a company with intitial optimism while effectively expressing where further homework is necessary. Sort of "how to find on-line expertise". I have a friend, Mike Solomon at Wisconsin (Pharmaceutical Chem), who was targeted on the "how selective" question with ARIA over six months ago. Unfortunately (from the perspective of obtaining more ARIA-related news, not from any other sane view) he is scrambling with 18 hour days to finish his thesis. His first-blush look at the selectivity issue left a positive impression. But, you're correct, there's lots downstream and I also need to look further at the issue. With respect to your "4 of 4" comment...... there are some good analysts out there, and at least one of them (Michael King at Vector) covers ARIA. However, I am less enthusiastic about using Zack's-like numbers than you. That is, I feel that most biotech analysts are clowns with vested interests. Cheers! Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next